Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Risk factors of amphotericin B toxicty in the nonneonatal pediatric population.

Dutta A, Palazzi DL.

Pediatr Infect Dis J. 2012 Sep;31(9):910-4. doi: 10.1097/INF.0b013e31825d649a.

PMID:
22581225
2.
5.

Continuous infusion of amphotericin B: preliminary experience at Faculdade de Medicina da Fundação ABC.

Uehara RP, Sá VH, Koshimura ET, Prudente FV, Tucunduva LT, Gonçalves MS, Samano ES, del Giglio A.

Sao Paulo Med J. 2005 Sep 1;123(5):219-22. Epub 2005 Dec 8.

6.
7.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
8.

Impact of liposomal amphotericin B on renal function in critically ill patients with renal function impairment.

Alvarez-Lerma F, Soriano MC, Rodríguez M, Catalán M, Llorente AM, Vidart N, Garitacelaya M, Maraví E, Fernández E, Alvarado F, López M, Alvarez-Sánchez B, Espinosa J, Quintana E; Study Group of Liposomal Amphotericin B in the ICU.

Rev Esp Quimioter. 2012 Sep;25(3):206-15.

9.

Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex.

Wade RL, Chaudhari P, Natoli JL, Taylor RJ, Nathanson BH, Horn DL.

Diagn Microbiol Infect Dis. 2013 Jul;76(3):361-7. doi: 10.1016/j.diagmicrobio.2013.04.001.

PMID:
23774005
10.

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS.

N Engl J Med. 1999 Mar 11;340(10):764-71.

11.

Evaluating real-life clinical and economical burden of amphotericin-B deoxycholate adverse reactions.

Horwitz E, Shavit O, Shouval R, Hoffman A, Shapiro M, Moses AE.

Int J Clin Pharm. 2012 Aug;34(4):611-7. doi: 10.1007/s11096-012-9654-y. Epub 2012 Jun 7.

PMID:
22674178
12.

Safety analysis of liposomal amphotericin B in adult patients: anaemia, thrombocytopenia, nephrotoxicity, hepatotoxicity and hypokalaemia.

Shigemi A, Matsumoto K, Ikawa K, Yaji K, Shimodozono Y, Morikawa N, Takeda Y, Yamada K.

Int J Antimicrob Agents. 2011 Nov;38(5):417-20. doi: 10.1016/j.ijantimicag.2011.07.004. Epub 2011 Aug 31.

PMID:
21885259
13.

An evaluation of hepatotoxicity and nephrotoxicity of liposomal amphotericin B (L-AMB).

Patel GP, Crank CW, Leikin JB.

J Med Toxicol. 2011 Mar;7(1):12-5. doi: 10.1007/s13181-010-0120-8.

14.

A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.

Maertens JA, Madero L, Reilly AF, Lehrnbecher T, Groll AH, Jafri HS, Green M, Nania JJ, Bourque MR, Wise BA, Strohmaier KM, Taylor AF, Kartsonis NA, Chow JW, Arndt CA, DePauw BE, Walsh TJ; Caspofungin Pediatric Study Group.

Pediatr Infect Dis J. 2010 May;29(5):415-20. doi: 10.1097/INF.0b013e3181da2171.

PMID:
20431381
15.
16.

Experience with community-based amphotericin B infusion therapy.

Malani PN, Depestel DD, Riddell J, Bickley S, Klein LR, Kauffman CA.

Pharmacotherapy. 2005 May;25(5):690-7.

PMID:
15899731
17.

Characterizing and predicting amphotericin B-associated nephrotoxicity in bone marrow or peripheral blood stem cell transplant recipients.

Gubbins PO, Penzak SR, Polston S, McConnell SA, Anaissie E.

Pharmacotherapy. 2002 Aug;22(8):961-71.

PMID:
12173799
18.

Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.

Shehab N, DePestel DD, Mackler ER, Collins CD, Welch K, Erba HP.

Pharmacotherapy. 2007 Jul;27(7):970-9.

PMID:
17594202
19.

[Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].

Rieger CT, Dittmer M, Ostermann H.

Dtsch Med Wochenschr. 2007 Oct;132(40):2062-6. German.

PMID:
17899499
20.
Items per page

Supplemental Content

Write to the Help Desk